In order to comply with the CMS Covered Outpatient Drug Rule, states have implemented a variety of strategies to establishing 340B Medicaid policy through state plan amendments (SPAs). This session will provide an overview of the approaches states have taken that impact health centers, the trends nationally that have emerged, and both long- and short-term anticipated consequences. Pharmacy leadership from health centers will describe their experience working with Medicaid on 340B polices, as well as the risks and opportunities they have encountered. Presenters will focus on the unique experiences of health centers, based upon lessons learned in this emerging area.
- Describe the trends in state policy regarding 340B Medicaid reimbursement and duplicate discount prevention.
- Discuss risks to FQHCs with different Medicaid 340B policy trends.
- Identify opportunities for FQHCs based upon best practice experiences with states.
Manager, 340B Education and Compliance Support,